R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The Alderley Park Discovery Podcast: The journey to accessin...

Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors.

R&D

International Women's Day: The gender gap in clinical trials

For International Women’s Day, Medidata's global compliance and strategy principal Fiona Maini discusses the importance of increasing female participation in clinical trials and how technol

Views & Analysis

Focus on Rare: the invisible burden of rare diseases

Emma Sutcliffe from NexGen Healthcare Communications looks at how patient insights can bring the invisible challenges of living with a rare condition into plain view.

Views & Analysis

Could personalised medicine change treatment for migraine?

The concept of personalised medicine is becoming established in cancer, with an increasing number of drugs targeting specific mutations making it to market.

Views & Analysis

The post-COVID face of pharma research and development

The acute phase of the COVID-19 pandemic not only brought delays, restrictions, and reconfigurations to pharmaceutical research & development in 2020, but also a more flexible response

Views & Analysis

Why AI equity is the next step for transformational pharma

AI can be transformative for all areas of healthcare, but often these systems are built off biased datasets that don’t reflect the true diversity of the general public – leading to approach

The Alderley Park Discovery Podcast: The journey to accessin...

International Women's Day: The gender gap in clinical trials

Focus on Rare: the invisible burden of rare diseases

Could personalised medicine change treatment for migraine?

The post-COVID face of pharma research and development

Why AI equity is the next step for transformational pharma

UK seeks views on indefinite CE marks for medical devices

How to meet your physicians where they are online

Views & Analysis

Editor's Picks